Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about OCT4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
OCT4 is a concept in neurodegeneration research. Key relationships include: therapeutic target, activates, regulates. Associated with Aging, Als, Alzheimer. Connected to 144 entities in the SciDEX knowledge graph.
| Name | OCT4 |
| Key Genes/Proteins | SOX2 |
| Related Diseases | Pluripotency, Aging, Tumor, Cancer, Als |
| Related Pathways | cellular_reprogramming |
Knowledge base pages for this entity
graph TD
OCT4["<b>OCT4</b>"]
OCT4 -->|"activates"| Pluripotency["Pluripotency"]
OCT4 -->|"involved_in"| Self_Renewal["Self-Renewal"]
OCT4 -->|"activates"| cellular_reprogramming["cellular_reprogramming"]
OCT4 -.biomarker for.-> Aging["Aging"]
OCT4 -->|"activates"| Senescence["Senescence"]
OCT4 -->|"activates"| Cardiovascular["Cardiovascular"]
OCT4 -->|"activates"| Tumor["Tumor"]
OCT4 -->|"activates"| Neurodegeneration["Neurodegeneration"]
OCT4 -->|"regulates"| Alzheimer["Alzheimer"]
OCT4 -->|"expressed in"| Carcinoma["Carcinoma"]
Melatonin["Melatonin"] -->|"upregulates"| OCT4
h_baba5269["h-baba5269"] -->|"targets"| OCT4
MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| OCT4
POU5F1["POU5F1"] -->|"activates"| OCT4
AND["AND"] -->|"activates"| OCT4
DNA["DNA"] -->|"activates"| OCT4
KLF4["KLF4"] -->|"activates"| OCT4
MYC["MYC"] -.biomarker for.-> OCT4
GENES["GENES"] -->|"activates"| OCT4
AGING["AGING"] -.biomarker for.-> OCT4| Target | Relation | Type | Str |
|---|---|---|---|
| iPSC Reprogramming | involved_in | process | 0.95 |
| Pluripotency | activates | phenotype | 0.90 |
| Self-Renewal | involved_in | process | 0.90 |
| Pluripotency | associated_with | phenotype | 0.90 |
| Pluripotency | promotes | process | 0.90 |
| Cellular Senescence | associated_with | process | 0.85 |
| cellular_reprogramming | activates | pathway | 0.80 |
| SOX2 | regulates | gene | 0.80 |
| Aging | expressed_in | disease | 0.75 |
| Tumor | therapeutic_target | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Tumor | inhibits | disease | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| KLF4 | regulates | gene | 0.70 |
| AKT | therapeutic_target | gene | 0.70 |
| MTOR | therapeutic_target | gene | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| Mtor | therapeutic_target | pathway | 0.70 |
| CANCER | inhibits | gene | 0.70 |
| Metastasis | inhibits | pathway | 0.70 |
| Stem Cell | inhibits | pathway | 0.70 |
| Aging | biomarker_for | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Senescence | expressed_in | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Leukemia | therapeutic_target | disease | 0.65 |
| Breast Cancer | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| neurodegeneration | implicated_in | disease | 0.60 |
| POU5F1 | activates | gene | 0.60 |
| SOX2 | activates | gene | 0.60 |
| KLF4 | activates | gene | 0.60 |
| MYC | biomarker_for | gene | 0.60 |
| SOX2 | biomarker_for | gene | 0.60 |
| DNMT3A | activates | gene | 0.60 |
| KLF4 | biomarker_for | gene | 0.60 |
| SOX2 | interacts_with | gene | 0.60 |
| SOX2 | expressed_in | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SOX2 | interacts_with | gene | 0.90 |
| h-baba5269 | targets_gene | hypothesis | 0.90 |
| h-baba5269 | targets | hypothesis | 0.80 |
| AGING | expressed_in | gene | 0.70 |
| POU5F1 | activates | gene | 0.60 |
| KLF4 | activates | gene | 0.60 |
| MYC | biomarker_for | gene | 0.60 |
| KLF4 | biomarker_for | gene | 0.60 |
| DNMT3A | activates | gene | 0.60 |
| KLF4 | regulates | gene | 0.60 |
| CLOCK | associated_with | gene | 0.60 |
| KLF4 | expressed_in | gene | 0.60 |
| PPAR | therapeutic_target | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| BECLIN1 | associated_with | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| PTEN | therapeutic_target | gene | 0.60 |
| BAX | inhibits | gene | 0.60 |
| PINK1 | inhibits | gene | 0.60 |
| CD44 | inhibits | gene | 0.60 |
| BNIP3 | inhibits | gene | 0.60 |
| SOX2 | biomarker_for | gene | 0.60 |
| SOX2 | activates | gene | 0.60 |
| SOX2 | regulates | gene | 0.60 |
| SOX2 | encodes | gene | 0.60 |
| CD38 | expressed_in | gene | 0.60 |
| CD44 | expressed_in | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| AGING | biomarker_for | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| MIRNAS | regulates | gene | 0.60 |
| AGING | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| EXOSOMES | therapeutic_target | gene | 0.60 |
| NF-ΚB | therapeutic_target | gene | 0.60 |
| AUTOPHAGY | inhibits | gene | 0.60 |
| ROS | associated_with | gene | 0.60 |
| AMPK | therapeutic_target | gene | 0.60 |
| P53 | therapeutic_target | gene | 0.60 |
| HIPPO | regulates | gene | 0.60 |
| MITOPHAGY | inhibits | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| C-MYC | biomarker_for | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Partial Neuronal Reprogramming via Modified Yamanaka Cocktai | 0.399 | neurodegeneration | Epigenetic reprogramming in aging neuron |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.670
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Engineered LINC MIR503HG-loaded extracellular vesicles maintain stemness and plu [PMID:41551196] | Zhu J, Zhu X, Feng W, Jin Y, Ge X et al. | Bioact Mater | 2026 | 0 |
| Development of a practical GMP-compliant manufacturing process for T cell-derive [PMID:41691922] | Hulspas R, Sasso C, Cunningham A, Cancel | Cytotherapy | 2026 | 0 |
| Establishment of a human induced pluripotent stem cell line (BTHBIOi005-A) from [PMID:41713384] | Liu ZY, Zhang H, Zhang XH, Shen RJ, Jin | Stem Cell Res | 2026 | 0 |
| Dose-resolved control of somatic reprogramming by Rora. [PMID:41932336] | Wang H, Li Y, Yin C, Zhang Z, Wang Y et | Stem Cell Reports | 2026 | 0 |
| Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Re [PMID:38381405] | Macip CC, Hasan R, Hoznek V, Kim J, Lu Y | Cellular reprogramming | 2024 | 0 |
| Targeted partial reprogramming of age-associated cell states improves markers of [PMID:39259812] | Sahu SK, Reddy P, Lu J, Shao Y, Wang C, | Science translational medicine | 2024 | 0 |
| Development of a clinical polygenic risk score assay and reporting workflow. [PMID:35437332] | ["Hao L", "Kraft P", "Berriz G", "Hynes | Nature medicine | 2022 | 0 |
| Distinct hypothalamic control of same- and opposite-sex mounting behaviour in mi [PMID:33268894] | ["Karigo T", "Kennedy A", "Yang B", "Liu | Nature | 2021 | 0 |
| Predicting ambient PM [PMID:32747729] | ["Enebish T", "Chau K", "Jadamba B", "Fr | Journal of exposure science & | 2021 | 0 |
| Correction: MicroRNA signatures of TRAIL resistance in human non-small cell lung [PMID:33398039] | Garofalo M, Quintavalle C, Di Leva G, Za | Oncogene | 2021 | 0 |
| Mechanisms of OCT4-SOX2 motif readout on nucleosomes. [PMID:32327602] | Michael AK, Grand RS, Isbel L, Cavadini | Science (New York, N.Y.) | 2020 | 0 |
| The Use of Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish [PMID:32664640] | Biava PM | International journal of molec | 2020 | 0 |
| Tumour lineage shapes BRCA-mediated phenotypes. [PMID:31292550] | ["Jonsson P", "Bandlamudi C", "Cheng M", | Nature | 2019 | 0 |
| Cooperative Binding of Transcription Factors Orchestrates Reprogramming. [PMID:28111071] | Chronis C, Fiziev P, Papp B, Butz S, Bon | Cell | 2017 | 0 |
| Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice. [PMID:28877458] | ["Newman J", "Covarrubias A", "Zhao M", | Cell metabolism | 2017 | 0 |
| In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. [PMID:27984723] | ["Ocampo A", "Reddy P", "Martinez-Redond | Cell | 2016 | 0 |
| Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman pr [PMID:25297091] | ["Forny-Germano L", "Lyra e Silva N", "B | The Journal of neuroscience : | 2014 | 0 |
| Structure and interactions of the human programmed cell death 1 receptor. [PMID:23417675] | ["Cheng X", "Veverka V", "Radhakrishnan | The Journal of biological chem | 2013 | 0 |
| Location and cellular stages of natural killer cell development. [PMID:24055329] | ["Yu J", "Freud A", "Caligiuri M"] | Trends in immunology | 2013 | 0 |
| A molecular roadmap of reprogramming somatic cells into iPS cells. [PMID:23260147] | ["Polo J", "Anderssen E", "Walsh R", "Sc | Cell | 2012 | 0 |